Embolization for fluid buildup in advanced cirrhosis
Part of Digestive system clinical trials.
This study tests a procedure called proximal splenic artery embolization (PSAE) to treat fluid buildup in the belly (ascites) that doesn't get better with standard medicines. The procedure blocks some blood flow to the spleen, which may reduce the pressure that causes ascites and reduce the need for frequent drainage procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cirrhosis that has led to fluid buildup in your belly (ascites) that is not controlled by maximum doses of water pills (diuretics) and has required a drainage procedure (paracentesis) at least twice a month for the past 3 months.
- You are not a good candidate for a procedure called TIPS (a shunt to relieve pressure in the liver), either because of medical reasons or anatomy.
- You do not have other causes of high blood pressure in the liver, such as blood clots or heart problems.
- You have had a CT or MRI scan within the last 60 days showing that the main veins of your liver and spleen are open and no reason to avoid the procedure.
- You are expected to live at least 6 more months and are willing to follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure to block abnormal blood vessels in the liver that bypass normal filtering, which causes confusion and brain problems in people with advanced liver disease. The goal is to reduce these episodes by redirecting blood flow through the liver where it can be properly cleaned.
This study tests whether placing a small tube (called a TIPS) early in the liver can help people with cirrhosis who have their first episode of moderate to severe belly fluid buildup. The goal is to see if this early procedure improves outcomes compared to standard care.
This trial compares a surgery called LSD with a procedure called TIPS to see which is better at preventing rebleeding in people with liver cirrhosis and an enlarged spleen. It may help if you have had bleeding from veins in your esophagus or stomach that came back after treatment.
This study tests a special surgery using a nerve-guided technique to remove the enlarged spleen and reduce bleeding risk in people with cirrhosis and portal hypertension. It may help if you have an enlarged spleen and have had bleeding related to liver disease.
This study uses a special ultrasound with a contrast agent to see if it can diagnose PSVD (a rare liver vessel disorder) without a biopsy. It compares people with PSVD to those with cirrhosis to find better, noninvasive ways to detect this condition.
This trial tests if apixaban, a blood thinner, is more effective than aspirin at treating blood clots in the portal vein that form more than a year after laparoscopic spleen removal in people with cirrhosis and an enlarged spleen.
Hear when a new Ascites trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.